Sjögren's syndrome
Autoimmune disease that destroys moisture-producing glands — classically causing dry eyes and dry mouth — but with systemic features (joint pain, fatigue, lymphoma risk) that elevate it above a cosmetic nuisance.
What it is
Sjögren's syndrome is a chronic autoimmune disorder in which lymphocytes infiltrate and damage exocrine glands, especially lacrimal (tear) and salivary. Symptoms span from purely glandular (xerophthalmia, xerostomia) to systemic — fatigue, polyarthralgia, Raynaud's, interstitial lung disease, peripheral neuropathy, and a 5–20 fold increased risk of non-Hodgkin lymphoma. Primary Sjögren's stands alone; secondary forms accompany rheumatoid arthritis, lupus or systemic sclerosis. Predominantly affects women (9:1) in the 40s–60s. Diagnosis combines symptoms, objective dryness measurement (Schirmer test, salivary flow), autoantibody profile (anti-Ro/SSA, anti-La/SSB, ANA) and minor salivary gland biopsy when needed.
Key lab markers
- ANA — positive in 60–80%; often speckled pattern.
- Anti-Ro/SSA, anti-La/SSB — specific autoantibodies; combined positive in ~50% (most diagnostic).
- ESR, CRP — often mildly elevated; CRP usually only modestly so.
- Liver enzymes (ALT, ALP, GGT) — sometimes raised when overlap with primary biliary cholangitis.
- Rheumatoid factor — positive in ~50% even without RA.
- CBC — mild cytopenias possible.
Symptoms
- Persistent dry, gritty eyes; sensation of foreign body
- Dry mouth, difficulty swallowing dry food, accelerated dental caries
- Bilateral parotid swelling
- Joint pain without destructive arthritis
- Profound fatigue out of proportion to other symptoms
- Raynaud's phenomenon; vaginal dryness; chronic non-productive cough
When to discuss with a doctor
Persistent dryness of eyes and mouth for >3 months, combined with fatigue, joint pain or family history of autoimmune disease, warrants rheumatology referral and testing for ANA + anti-Ro/SSA + anti-La/SSB. Confirmed Sjögren's needs annual screening for lymphoma (CBC, exam, sometimes imaging) and dental review every 6 months because of caries risk. Mediora.AI flags the autoantibody pattern and inflammation markers; objective dry-gland testing requires an ophthalmologist or dentist.